Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Net Equity Issued and Repurchased (2012 - 2013)

Iqvia Holdings' (IQV) quarterly Net Equity Issued and Repurchased came in at $35.4 million in Q4 2013, up 1574.86% year-over-year from $2.1 million in Q4 2012, and up 9401.84% quarter-over-quarter from -$381000.0 in Q3 2013.

Analysis

Iqvia Holdings (IQV) Net Equity Issued and Repurchased (2012 - 2013) Analysis & Trends

Iqvia Holdings has disclosed Net Equity Issued and Repurchased across 2 years of filings, most recently posting $35.4 million for Q4 2013.

  • In Q4 2013, Net Equity Issued and Repurchased rose 1574.86% year-over-year to $35.4 million; the TTM figure through Dec 2013 stood at $525.0 million (changed N/A YoY), while the FY2019 annual figure was $11.0 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased came in at $35.4 million for Q4 2013 at Iqvia Holdings, up from -$381000.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $489.8 million in Q2 2013 to a low of -$381000.0 in Q3 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 35.44 Mn
Sep 30, 2013 -381,000.00
Jun 30, 2013 489.79 Mn
Mar 31, 2013 149,000.00
Dec 31, 2012 2.12 Mn